Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Mankind Pharma Ltd. ( (IN:MANKIND) ) has issued an update.
Mankind Pharma Ltd. has received an ESG rating score of 69 from CFC Finlease Private Limited, an independent SEBI-registered ESG rating provider. This rating, which was not solicited by the company, reflects its performance in environmental, social, and governance aspects, potentially impacting its reputation and stakeholder perceptions.
More about Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of a wide range of healthcare products. The company is known for its commitment to providing affordable and quality medicines, catering to various therapeutic areas and market segments.
Average Trading Volume: 10,251
Technical Sentiment Signal: Sell
Current Market Cap: 992.6B INR
Learn more about MANKIND stock on TipRanks’ Stock Analysis page.

